The Radioisotopes and Radioactive Drug Research Advisory Committee is charged with the responsibility for review, approval, and surveillance of radioactive drugs, as well as the purchase and use of radioisotopes in humans (including research and routine) within the University of Chicago and University of Chicago Medical Center.